• A Dual-Center study: Can ultrasound radiomics differentiate type I and type II epithelial ovarian cancer patients with normal CA125 levels?
• A randomized phase II study of secondary cytoreductive surgery in patients with relapsed ovarian cancer who have progressed on a PARP inhibitor as first-line maintenance therapy: the SOCCER-P study (KGOG 3067/JGOG 3036/APGOT-OV11)
• A rare case of anterior sternal metastasis in ovarian cancer: A case report
• A retrospective analysis of haematological side effects of olaparib in excess-weight and normal BMI patients with ovarian cancer
• Advanced cytoreductive procedures: patient positioning and exposition maneuvers in 10 steps
• Agreement between frozen section and histopathology to detect malignancy in adnexal masses according to size and morphology by ultrasound
• An oncolytic adenovirus co-expressing a bi-specific T cell engager and IL-2 for the treatment of ovarian cancer
• Application of PARP inhibitors combined with immune checkpoint inhibitors in ovarian cancer
• Association between gynecologic cancer and Alzheimer's disease: a bidirectional mendelian randomization study
• Association of insulin-like growth factor II mrna-binding protein 3 (IMP3) expression with prognostic and morphological factors in endometrial cancer
• B cells critical for outcome in high grade serous ovarian carcinoma
• Body Mass Index and Risk of Female Reproductive System Tumors Subtypes: A Meta-Analysis Using Mendelian Randomization
• Can CA-125/CEA ratio be used for the differential diagnosis between ovarian and non-ovarian cancers? A research letter
• Cancer-Related Morbidity Among Patients Conceiving Through Oocyte Donation: A Healthcare Registry Cohort Study
• Causal relationship between gut microbiota and gynecological tumor: a two-sample Mendelian randomization study
• Changes in modifiable risk factors in women at increased risk for breast and ovarian cancer during the COVID-19 pandemic
• Chemotherapy drives tertiary lymphoid structures that correlate with ICI-responsive TCF1+CD8+ T cells in metastatic ovarian cancer
• Combined Transcriptome and Circulating Tumor DNA Longitudinal Biomarker Analysis Associates With Clinical Outcomes in Advanced Solid Tumors Treated With Pembrolizumab
• Comparison of serum Vascular Cell Adhesion Molecule (VCAM) level among epithelial ovarian cancer patients and healthy women
• Comprehensive analysis of consensus molecular subtypes for ovarian cancer from bulk to single-cell perspectives
• Construction of a prognostic model for ovarian cancer based on a comprehensive bioinformatics analysis of cuproptosis-associated long non-coding RNA signatures
• Construction of scalable multi-channel DNA nanoplatform for the combined detection of ctDNA biomarkers of ovarian cancer
• Correction to Cervicovaginal specimen biomarkers for early detection of ovarian and endometrial cancer: A review
• Cost of ovarian cancer by the phase of care in the United States
• CXCL12-loaded-hydrogel (CLG): A new device for metastatic circulating tumor cells (CTCs) capturing and characterization
• Deciphering the needs of patients with hereditary breast and ovarian Cancer in the Process of Genetic Counseling to Inform the Development of a Mobile Support App: a qualitative study in Germany
• Diagnostic performance of a modified O-RADS classification system for adnexal lesions incorporating clinical features
• Effect of emergent nephrostomy on long-term total and split renal function in patients with upper urinary tract obstruction due to pelvic malignant tumors
• Effects of curcumin nanoparticles on the proliferation and migration of human ovarian cancer cells assessed through the NF-kappaB/PRL-3 signaling pathway
• Efficacy and safety of oxaliplatin-based hyperthermic intraperitoneal chemotherapy with secondary cytoreduction for platinum resistant recurrent ovarian cancer: A single-center retrospective cohort study
• Epigenetic regulation in ovarian cancer
• Epigenetic Therapy in a Rare Ovarian Cancer - A Double-Edged Sword
• ETS1 drives EGF-induced glycolytic shift and metastasis of epithelial ovarian cancer cells
• Evaluation of risk prediction models to select lung cancer screening participants in Europe: a prospective cohort consortium analysis
• Exploring the anticancer potential of new 3-cyanopyridine derivatives bearing N-acylhydrazone motif: Synthesis, DFT calculations, cytotoxic evaluation, molecular modeling, and antioxidant properties
• Exploring the impact of BRCA1 and BRCA2 mutation type and location on Olaparib maintenance therapy in platinum-sensitive relapsed ovarian Cancer patients: A single center report
• Expression and clinical significance of CLDN7 and its immune-related cells in breast cancer
• Expression and clinical significance of KDM5A, KDM5B, and FOXO1 in endometrial cancer
• Fertility protection during chemotherapy treatment by boosting the NAD(P)⁺ metabolome
• From symptoms to surgery-A pathway through uncertainty and hope: An interview study of women facing ovarian surgery
• Gynecological cancer tumor Microenvironment: Unveiling cellular complexity and therapeutic potential
• hsa_circ_0020093 suppresses ovarian cancer progression by modulating LRPPRC activity and miR-107/LATS2 signaling
• Identification of energy metabolism anomalies and serum biomarkers in the progression of premature ovarian failure via extracellular vesicles' proteomic and metabolomic profiles
• Immunoaffinity-free chromatographic purification of ovarian cancer biomarker CA125 (MUC16) from blood serum enables mass spectrometry characterization
• In-depth analysis of transcriptomes in ovarian cortical follicles from children and adults reveals interfollicular heterogeneity
• Indirect reference interval estimation using a convolutional neural network with application to cancer antigen 125
• Induction of circulating ABCB1 transcripts under platinum-based chemotherapy indicates poor prognosis and a bone micrometastatic phenotype in ovarian cancer patients
• Information needs of women with BRCA mutations regarding cancer risk management and decision-making
• Innovations in Rare Gynecologic Cancer: Melanoma, Neuroendocrine, and Low-Grade Serous Ovarian
• Investigating the timing and site of recurrence for ovarian clear cell carcinoma: Analysis of the JGOG/GCIG trial-JGOG 3017-A3
• ISGylation enhances double-stranded RNA-induced interferon response and NFκB signaling in fallopian tube epithelial cells
• Learning curve of ovarian cystectomy by vaginal natural orifice transluminal endoscopic surgery: a cumulative sum analysis
• lncRNA BC200 is processed into a stable Alu monomer
• Lung adenocarcinoma metastatic to the ovary: a retrospective clinicopathological analysis of 17 cases and literature review
• Machine learning analysis of oxidative stress-related phenotypes for specific gene screening in ovarian cancer
• Mapping spatial organization and genetic cell-state regulators to target immune evasion in ovarian cancer
• Menopausal Hormone Therapy and Ovarian and Endometrial Cancers: Long-Term Follow-Up of the Women's Health Initiative Randomized Trials
• MetDecode: Methylation-based deconvolution of cell-free DNA for non-invasive multi-cancer typing
• MiR-93-5p inhibits ovarian cancer through SLC7A11-mediated-ferroptosis
• MSH6 germline mutations leading to Lynch syndrome-associated cholangiocarcinoma: a case report
• Mucinous Carcinoma of Ovary in a 15-Year-Old Girl, A Rare Case Report and Literature Review
• Neurological toxicities with poly (ADP-ribose) polymerase inhibitors in cancer patients: a systematic review and meta-analysis
• Niraparib plays synergistic antitumor effects with NRT in a mouse ovarian cancer model with HRP
• NK cell line modified to express a potent, DR5 specific variant of TRAIL, show enhanced cytotoxicity in ovarian cancer models
• Olaparib induced aplastic anemia in a patient with castrate resistant prostate cancer: A case report
• Ovarian Cancer Risk Prediction - a Clinical Epidemiology Perspective
• Overall survival in ovarian cancer patients after cytoreductive surgery. A systematic review and meta-analysis
• Overcoming Resistance in Cancer Therapy: Computational Exploration of PIK3CA Mutations, Unveiling Novel Non-Toxic Inhibitors, and Molecular Insights Into Targeting PI3Kalpha
• p53 Abnormal (Copy Number High) Endometrioid Endometrial Carcinoma Has a Prognosis Indistinguishable From Serous Carcinoma
• Palmdelphin Inhibits Ovarian Cancer Cell Stem Specification via Downregulating Ring Finger Protein 145
• Pan-cancer analysis reveals GGPS1 plays an important role in tumorigenesis in multiple tumor types
• Physician-reported patient involvement and treatment decisions in first-line ovarian cancer in the USA and Europe
• Potentially functional variants of INPP5D and EXOSC3 in immunity B cell-related genes are associated with non-small cell lung cancer survival
• Predicting progression-free survival in patients with epithelial ovarian cancer using an interpretable random forest model
• Probing the relevance of BRCA1 and BRCA2 germline pathogenic variants beyond breast and ovarian cancer
• Prognostic effect of the pretreatment prognostic nutritional index in cervical, ovarian, and endometrial cancer: a meta-analysis
• Protocol for quantifying drug sensitivity in 3D patient-derived ovarian cancer models
• Quality of life and survivorship in patients with low-grade ovarian cancer
• Reproductive outcomes in women with BRCA 1/2 germline mutations: A retrospective observational study and literature review
• Risk-stratified screening and colorectal cancer incidence and mortality: A retrospective study from the prostate, lung, colorectal, and ovarian cancer screening trial
• Safety and efficacy of anticoagulant treatment in patients with ovarian vein thrombosis: a systematic review and meta-analysis of observational studies
• Sexual Dysfunction in Women
• Single-cell RNA transcriptomic analyses of tumor microenvironment of ovarian metastasis in gastric cancer
• Single-sample gene set enrichment analysis reveals the clinical implications of immune-related genes in ovarian cancer
• Stage IC grade 1 endometrioid adenocarcinoma of the ovary: assessment of post-operative chemotherapy de-escalation
• Streamlined Genetic Education and Cascade Testing in Men from Hereditary Breast Ovarian Cancer Families: A Randomized Trial
• SUGT1 regulates the progression of ovarian cancer through the AKT/PI3K/mTOR signaling pathway
• Survival analysis of gynecological cancers in Southeast China, 2011-2020: A population-based study
• Synchronous endometrial endometrioid adenocarcinoma and ovarian endometrioid adenocarcinoma
• The association of maintenance hormone therapy with overall survival in advanced-stage low-grade serous ovarian carcinoma: A risk-set matched retrospective study
• The clinical importance of IFN-gamma and human epididymis protein 4 in Egyptian patients with epithelial ovarian cancer combined with HPV infection
• The guidelines for clinical practice for carriers of germline mutations in hereditary breast, ovarian, prostate, and pancreatic cancer predisposition genes BRCA1, BRCA2, PALB2, ATM, and CHEK2 (4.2024)
• The recent advance and prospect of poly(ADP-ribose) polymerase inhibitors for the treatment of cancer
• The Role of hBRCA2 in the Repair of Spontaneous and UV DNA Damage in <em>Saccharomyces cerevisiae</em>
• The Roles of Ovarian-Adnexal Reporting and Data System US and Ovarian-Adnexal Reporting and Data System MRI in the Evaluation of Adnexal Lesions
• The TWIK-related acid sensitive potassium 3 (TASK-3) channel contributes to the different effects of anesthetics on the growth and metastasis of ovarian cancer cells
• Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer
• Unusual radiologic imaging in juvenile granulosa cell tumor with precocious puberty: A unilocular cyst
• Use of tamoxifene-controlled ovarian hyperstimulation for fertility preservation before breast cancer treatment: A prospective cohort study with a 5-year follow-up
• Utility and Outcomes of Ovarian Tissue Cryopreservation and Transplantation for Gynecologic Cancers: A Systematic Review and Meta-analysis